LISA ARRASMITH: Open Payments
NPI 1437159936 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 33 payments from 12 companies in 2025. Trend: 2023 $1,456 · 2024 $1,570 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $147 |
| Neurocrine BioSciences, Inc. | 5 | $102 |
| Lundbeck LLC | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $41 |
| Alkermes, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: VRAYLAR, INGREZZA, ABILIFY MAINTENA, AUSTEDO XR, Auvelity, HETLIOZ, CAPLYTA, REXULTI.
Industry payments across KY — which companies pay providers there.
